Clinical Trial Update: Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Vitamin D supplementation for outcomes in Cutaneous Malignant Melanoma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Malignant Melanoma

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Cutaneous Malignant Melanoma | Phase 3 | Status: COMPLETED | Results posted: 2025-02-17